Tourmaline Bio, Inc.
TRML
$13.12
-$0.28-2.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.24M | -20.18M | -17.49M | -13.31M | -12.90M |
| Total Depreciation and Amortization | 9.00K | 10.00K | 10.00K | 10.00K | 11.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -197.00K | -432.00K | -497.00K | 188.00K | 3.74M |
| Change in Net Operating Assets | 1.53M | -2.85M | -33.00K | -1.81M | -198.00K |
| Cash from Operations | -20.89M | -23.44M | -18.01M | -14.92M | -9.35M |
| Capital Expenditure | -9.00K | -- | -- | -- | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.40M | -11.70M | -10.13M | -188.87M | 3.90M |
| Cash from Investing | 16.39M | -11.70M | -10.13M | -188.87M | 3.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 161.35M | 0.00 |
| Repurchase of Common Stock | -3.00K | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 68.14M |
| Cash from Financing | -3.00K | -1.00K | 0.00 | 161.35M | 68.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.50M | -35.14M | -28.14M | -42.44M | 62.68M |
